Urinary cytology is sensitive and specific for diagnosing and screening high-grade urothelial carcinomas (HGUC). The Paris System (TPS) for urinary cytology was introduced in 2016 to standardize reporting. According to TPS diagnostic categories of HGUC and suspicious for HGUC (SHGUC), the average nuclear-to-cytoplasm (N:C) ratio of atypical cells should be ≥0.7. The objective of the current study was to measure the N:C ratio of urine cytology specimens with HGUC and SHGUC diagnoses and biopsy-proven HGUC follow-up. METHODS: A cohort of 64 cases (HGUC, 49 cases; SHGUC, 15 cases) from 57 patients was constructed. Urine cytology slides were scanned into whole-slide digital images. The nuclear and cytoplasmic areas were enumerated by digital image analysis (DIA), and the N:C ratios were measured. RESULTS: In total, 640 cells were analyzed by DIA (HGUC, 490 cells; SHGUC, 150 cells). For HGUC and SHGUC, the average N:C ratios were 0.57 and 0.53, respectively. The maximum average N:C ratio was 0.73 for HGUC and 0.68 for SHGUC. HGUC had higher average N:C ratio (P < .001), higher average nuclear area (P < .001), higher average maximum N:C ratio (P = .005), and higher average maximum nuclear area (P = .006) compared with SHGUC.
INTRODUCTION
Urinary cytology is sensitive and specific for diagnosing and screening high-grade urothelial carcinomas (HGUCs). Previous reporting systems have been plagued with large numbers of equivocal diagnoses and inconsistent reporting. 1, 2 The Paris System (TPS) for urinary cytology was introduced in 2016 to standardize reporting. 3, 4 By placing an emphasis on HGUC, TPS has effectively reduced the number of "atypical urothelial cells" diagnoses and increased the number of "positive for HGUC" diagnoses in upper and lower tract urothelial carcinomas compared with the original diagnoses. [5] [6] [7] [8] [9] [10] [11] TPS is composed of a 7-tier reporting system with the following categories: 1) nondiagnostic/unsatisfactory, 2) negative for HGUC, 3) atypical urothelial cells (AUC), 4) suspicious for HGUC (SHGUC), 5) positive for low-grade urothelial carcinoma, 6) positive for HGUC, and 7) other (ie, metastatic disease). 3 
Shared diagnostic
Cancer Cytopathology February 2019 criteria between positive for HGUC and SHGUC include irregular nuclear membrane, nuclear hyperchromasia, coarse chromatin, and an average nuclear-to-cytoplasm (N:C) ratio of ≥0.7. SHGUC differs from HGUC based on the cellularity of the sample (SHGUC, <10 atypical cells). 3 Although TPS has enhanced the efficacy of urinary cytology, further improvements are feasible. Digital image analysis (DIA) is a tool that permits accurate quantification of cells in tissue specimens. [12] [13] [14] [15] [16] Recently, Hang et al examined cases that met TPS criteria for the AUC category that also had biopsy-proven positive and negative follow-up data. 17 By using DIA, those authors observed that the N:C ratio was the greatest predictor of malignancy. 17 They also generated receiver operating characteristic curves and established a maximum average N:C ratio of ≥0.5 as the best cutoff point. 17 To our knowledge, no such study exists for urine specimens with cytologic diagnoses of HGUC or SHGUC.
In the current study, we examined cases with cytologic diagnoses of HGUC and SHGUC in urine specimens which had biopsy-proven HGUC on follow-up. We calculated N:C ratio measurements of the malignant urothelial cells using DIA for accurate quantification.
MATERIALS AND METHODS

Patient Cohort
Cytologic diagnoses of HGUC and SHGUC were identified in the pathology files (2012-2018) at New York-Presbyterian Hospital/Weill Cornell Medicine. Only urine cytology specimens that were accessioned within 90 days of a surgical diagnosis of HGUC were included (Fig. 1) . All cytology cases were reviewed to confirm the diagnoses. Institutional review board approval was obtained for all aspects of this study.
Tumor Annotation and Digital Image Analysis
ThinPrep urine cytology slides were scanned using Aperio (Leica Biosystems, Buffalo Grove, IL) into wholeslide digital images at ×40 magnification. All scanning was performed with z-stacking. By using HALO imaging-analysis software (Indica Labs, Corrales, NM), image annotations of nuclear and cytoplasmic membranes were manually performed by a single pathologist (P.J.M.) ( Fig. 2 ). In accordance with TPS, which requires a minimum of 10 atypical urothelial cells for a diagnosis of HGUC, we chose to evaluate 10 cells per case of HGUC. For SHGUC, the 10 most atypical cells were analyzed. Cells with indistinct cell borders, disrupted cytoplasmic membranes, or marked nuclear degeneration were excluded.
Statistical Analysis
The nuclear and cytoplasmic areas were enumerated by DIA. The N:C ratio was calculated for each cell by dividing the nuclear area by the cytoplasmic area. A 2-sample t test (Student t test) was conducted to compare cohorts. All statistical tests were 2-sided, and α = .05 was used as the cutoff for the significance. . This is a cytology sample from a case that was deemed positive for high-grade urothelial carcinoma according to The Paris System (TPS). (A) This is an image of cells demonstrating high-grade cytologic features, including a nuclear-tocytoplasmic ratio ≥0.7, nuclear hyperchromasia, coarse chromatin, and nuclear membrane irregularity, meeting TPS criteria for high-grade urothelial carcinoma. (B) This is a hematoxylin and eosin-stained section from a surgical specimen with high-grade papillary urothelial carcinoma (original magnification ×40 in A and B).
RESULTS
Patient Characteristics
The characteristics of the patients in our cohort are summarized in Table 1 . The final cohort consisted of 64 specimens from 57 patients. There were 49 cases of HGUC (42 patients) and 15 cases of SHGUC (15 patients). The mean patient age was 75.5 years (range, 53-94 years). There were 38 men (66%), for a male-to-female ratio of 2.0. The majority of tumors were located in the bladder (43 of 64 tumors; 67%). Twelve tumors were located in the renal pelvis (19%), and 9 were located in the ureter (14%). Eleven upper tract tumors were on the left (52%), 8 were on the right (40%), and 2 were unspecified (10%).
Number of Cells Analyzed
In total, 640 cells (10 cells per case) were analyzed by DIA (HGUC, 490 cells; SHGUC, 150 cells). The cells with the largest N:C ratio and the cell with the largest nuclear area were identified in each case.
N:C Ratios Based on Categorical Classification
For HGUC, the average N:C ratio was 0.57 (range, 0.21-0.93), and the average nuclear area was 157. Table 2) .
For SHGUC, the average N:C ratio was 0.53 (range, 0.24-0.78), and the average nuclear area was 109.3 μm Table 2) . HGUC had a higher average N:C ratio (P < .001), higher average nuclear area (P < .001), higher average maximum N:C ratio (P = .005), and higher average maximum nuclear area (P = .006) compared with SHGUC (Table 2) . When comparing voided and washing specimens, a statistical difference (P > .05) was not identified.
DISCUSSION
Since its introduction in 2016, TPS has standardized the reporting of urine cytology specimens. By emphasizing the identification of HGUC, multiple studies have demonstrated that TPS has increased the number of Cancer Cytopathology February 2019
"positive for HGUC" diagnoses and reduced the number of "AUC" diagnoses compared with the original diagnoses. [5] [6] [7] [8] [9] [10] [11] Guidelines for HGUC and SHGUC include an N:C ratio ≥0.7 and nuclear hyperchromasia, in addition to the presence of coarse chromatin and/or an irregular nuclear membrane. 3 HGUC diagnoses are applied when criteria are met in ≥10 cells per sample. 3 SHGUC diagnoses are applied when the sample contains <10 cells meeting TPS criteria. 3 Hang et al used DIA to validate an N:C ratio cutoff of 0.5 for the AUC category, in keeping with TPS. 17 To date, there have been no studies validating a N:C ratio cutoff value ≥0.7 for the HGUC and SHGUC categories Such a study is necessary, because Layfield and colleagues demonstrated that, at the critical N:C ratio (range, 0.5-0.7), morphologists were less accurate and had moderate-to-poor interobserver concordance. 18 Zheng et al also demonstrated that morphologists tended to overestimate N:C ratio in this range. 19 In the current study, we demonstrated that, in our HGUC and SHGUC cohorts, the average N:C ratio was 0.57 and 0.53, respectively, which are lower than the current guideline recommendations. We propose reducing the average N:C ratio cutoff values for the HGUC and SHGUC categories to below the current 0.7 threshold. We have demonstrated that the maximum average N:C ratio in the HGUC and SHGUC cohorts was 0.73 and 0.68, respectively. In general, there was at least 1 malignant urothelial cell per case that met the current 0.7 threshold in both cohorts. We recommend that, although the average N:C ratio of the atypical cells in the sample may be below 0.7, a cytopathologist should be able to identify at least 1 malignant cell that meets current TPS guidelines (N:C ratio ≥0.7) before generating a diagnosis of HGUC or SHGUC.
Although the difference in the average HGUC and SHGUC N:C ratio was small (0.04), it was statistically significant, probably because of the high power of this study (n = 690 cells). In addition, we analyzed 10 cells per sample, including the cases of SHGUC. Although TPS guidelines dictate flagging only the most atypical cells for SHGUC, we were able to identified at least 10 atypical cells per case. Had fewer than 10 cells per case of SHGUC been analyzed, then we likely would have generated larger average N:C ratio and maximum average N:C ratio values.
Conclusion
Our current findings reveal that N:C ratios for the HGUC and SHGUC categories are lower than previously suggested by TPS. We present these data to the cytology community for formal and informal evaluation and further discussions regarding cutoff points. We advocate reducing the N:C ratio below the current threshold of 0.7. .006
Abbreviations: HGUC, high-grade urothelial carcinoma; N:C ratio, nuclearto-cytoplasm ratio; SHGUC, suspicious for high-grade urothelial carcinoma.
